Aktis Oncology
$16.51
78
-$0.86-4.95% Today
Statistics
Day High
17.63
Day Low
16.51
52W High
29.16
52W Low
14.72
Volume
112,915
Avg. Volume
422,317
Mkt Cap
51.18M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
3JunExpected
Expected EPS
-0.6425
Actual EPS
N/A
Financials
-1,009.51%Profit Margin
Unprofitable23.36MRevenue
-235.78MNet Income
Analyst Ratings
$31.33Average Price Target
The highest estimate is 33.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow AKTS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Akoustis Technologies, Inc., through its subsidiary, Akoustis, Inc., develops, designs, manufactures, and sells radio frequency (RF) filter products for the mobile wireless device industry in the United States. It operates through two segments, Foundry Fabrication Services and RF Filters. The Foundry Fabrication Services segment provides engineering review services; and semiconductor wafer-manufacturing and microelectromechanical systems foundry services. The RF Filters segment consists of amplifier and filter products. It offers RF filters for mobile wireless devices, such as smartphones and tablets, cellular infrastructure equipment, Wi-Fi customer premise equipment, and military and defense applications. The company was incorporated in 2013 and is headquartered in Huntersville, North Carolina.
Show more...
CEO
Mr. Todd Foley M.B.A.
Country
US
ISIN
US01021M1045
Listings
0 Comments
Share your thoughts
FAQ
What is Aktis Oncology stock price today?▼
The current price of AKTS is $16.51 USD — it has decreased by -4.95% in the past 24 hours. Watch Aktis Oncology stock price performance more closely on the chart.
What is Aktis Oncology stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Aktis Oncology stocks are traded under the ticker AKTS.
What is Aktis Oncology market cap?▼
Today Aktis Oncology has the market capitalization of 51.18M
When is the next Aktis Oncology earnings date?▼
Aktis Oncology is going to release the next earnings report on June 03, 2026.
What were Aktis Oncology earnings last quarter?▼
AKTS earnings for the last quarter are -1.46 USD per share, whereas the estimation was -21.59 USD resulting in a +93.26% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Aktis Oncology revenue for the last year?▼
Aktis Oncology revenue for the last year amounts to 23.36M USD.
What is Aktis Oncology net income for the last year?▼
AKTS net income for the last year is -235.78M USD.
When did Aktis Oncology complete a stock split?▼
The last stock split for Aktis Oncology was on April 24, 2015 with a ratio of 1.094891:1.
Where is Aktis Oncology headquartered?▼
Aktis Oncology is headquartered in Boston, US.